Presidential Science Aide Got Funding from Hwang
By Chosun Ilbo,
Chosun Ilbo
| 01. 17. 2006
The presidential advisor for science and technology Park Ky-young admitted Tuesday to a conflict of interest arising from W250 million (US$250,000) in research grants she received from the disgraced cloning scientist Hwang Woo-suk. Hwangîs motives have come under suspicion because although Park received the money when she was still a botanist at Sunchon National University in South Jeolla Province and before taking the Cheong Wa Dae post in 2004, she already had the presidentîs ear at the time. She insists the funding was spent in a transparent manner.
"I accepted W150 million from Hwang, who was in charge of producing a BSE-resistant cow in December 2001, when I was working as a botany professor at Sunchon National University, to carry out research projectsñ on social implications and research ethics, she said.
She said Hwang gave her another W100 million in June 2003, asking her to study the ethical and industrial impact of bio-organs, as part of a project on producing bio-organs by using transgenic cloning technology and developing transplant technology. Park was appointed presidential aide the following year.
The official...
Related Articles
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
